Malaysia is among the Top 30 in the world and leading in Southeast Asia in terms of country readiness for global clinical trials, according to the IQVIA report on Rethinking Clinical Trial Country Prioritization. The report, which was published earlier this month, had mapped global clinical trial opportunities according to country attributes, factoring 17 key metrics relevant to operational infrastructure, clinical infrastructure as well as patient availability. Key considerations include healthcare accessibility and quality, clinical trial efficiency, regulatory capabilities, streamlined business processes and investment opportunities. Source: BERNAMA News Agency